Literature DB >> 8781125

Molecular linkage of the mouse CD5 and CD6 genes.

O Lecomte1, J B Bock, B W Birren, D Vollrath, J R Parnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8781125     DOI： 10.1007/bf02602784

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  39 in total

1.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

Authors:  H Shizuya; B Birren; U J Kim; V Mancino; T Slepak; Y Tachiiri; M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1.

Authors:  N H Jones; M L Clabby; D P Dialynas; H J Huang; L A Herzenberg; J L Strominger
Journal:  Nature       Date:  1986 Sep 25-Oct 1       Impact factor: 49.962

3.  The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.

Authors:  L M Osorio; C A Garcia; M Jondal; S C Chow
Journal:  Cell Immunol       Date:  1994-03       Impact factor: 4.868

4.  Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.

Authors:  J L Ceuppens; M L Baroja
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

5.  Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex.

Authors:  E L Reinherz; S Meuer; K A Fitzgerald; R E Hussey; H Levine; S F Schlossman
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

6.  The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.

Authors:  H Van de Velde; I von Hoegen; W Luo; J R Parnes; K Thielemans
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

7.  Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA.

Authors:  I Von Hoegen; E Nakayama; J R Parnes
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

8.  A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.

Authors:  M Kamoun; M E Kadin; P J Martin; J Nettleton; J A Hansen
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Progenitors for Ly-1 B cells are distinct from progenitors for other B cells.

Authors:  K Hayakawa; R R Hardy; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells.

Authors:  C Y Wang; R A Good; P Ammirati; G Dymbort; R L Evans
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307
View more
  6 in total

1.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

2.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

3.  Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.

Authors:  Sergi Casadó-Llombart; Hoda Gheitasi; Silvia Ariño; Marta Consuegra-Fernández; Noelia Armiger-Borràs; Belchin Kostov; Manuel Ramos-Casals; Pilar Brito-Zerón; Francisco Lozano
Journal:  Front Med (Lausanne)       Date:  2022-03-18

4.  Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.

Authors:  Sergi Casadó-Llombart; María Velasco-de Andrés; Cristina Català; Alejandra Leyton-Pereira; Rebeca Gutiérrez-Cózar; Belén Suárez; Noelia Armiger; Esther Carreras; Miriam Esteller; Elena Ricart; Ingrid Ordás; Javier P Gisbert; María Chaparro; María Esteve; Lucía Márquez; David Busquets; Eva Iglesias; Esther García-Planella; María Dolores Martín-Arranz; Juliane Lohmann; C Korcan Ayata; Jan Hendrik Niess; Pablo Engel; Julián Panés; Azucena Salas; Eugeni Domènech; Francisco Lozano
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

Review 5.  Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6.

Authors:  Sergi Casadó-Llombart; María Velasco-de Andrés; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Elena Bosch
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

6.  CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Authors:  Andrea Moreno-Manuel; Eloisa Jantus-Lewintre; Ines Simões; Fernando Aranda; Silvia Calabuig-Fariñas; Esther Carreras; Sheila Zúñiga; Yvonne Saenger; Rafael Rosell; Carlos Camps; Francisco Lozano; Rafael Sirera
Journal:  Transl Lung Cancer Res       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.